Latest news

Our most recent publication sheds light on the common Sino-German view on functional safety issues in the Industrie 4.0/Intelligent Manufacturing environment. The paper elaborates on the rising complexity and interconnection among systems and analyses existing standards, specifications and provides recommendations to achieve safety.

In business with China, divergent standards, double certification requirements and unclear regulatory procedures often pose major obstacles for companies. The online exchange "Regulatory challenges in doing business with China" in cooperation with the OAV, presented current regulatory changes as well as GPQI support offers to the participants.

On 22 May 2020, the annual government work report for 2020 was published at the so-called "Two Sessions" of the National People's Congress (NPC) and the Chinese People's Political Consultative Conference (CPPCC). The State Council issued relevant guidelines on 6 June for the implementation designating specific ministries responsible for each priority area.

Exporte von Medizinprodukten und persönlicher Schutzausrüstung (PSA), wie Atemmasken aus China, haben durch COVID-19 stark zugenommen. Nachdem China als Reaktion auf Medienberichte über fehlerhafte chinesische Produkte in Europa seine Ausfuhrbedingungen verschärft hatte, wurden diese Ende April 2020 noch einmal angepasst.

The COVID-19 pandemic has led to a worldwide surge in demand for medical devices and personal protective equipment (PPE), including in Germany and Europe. During this critical time, GPQI is supporting both German and Chinese authorities to ensure product quality and safety of critical equipment.

Chinese ministries jointly declared the extension of controls on the export of certain medical devices. The declared aim of the measure is to ensure product quality and safety when exporting medical products manufactured in China, which are in high demand worldwide in the wake of the corona pandemic.

To top